Social impact Position dQ&A as a partner that translates patient voices into actionable product and policy insights, emphasizing its independence and patient-centric credibility to win collaborations with pharma, medical device makers, and health tech platforms seeking qualitative and quantitative diabetes research.

Niche expertise Leverage their decade-long focus on diabetes to target organizations prioritizing diabetic care outcomes, giving proposals that highlight proprietary community access, rapid insights, and a blend of qualitative and quantitative methods to shorten decision cycles.

Platform fit Cross-sell with platforms or services that rely on patient cohorts and real-world input, such as market access, patient-reported outcomes, and post-market surveillance, using their tech stack familiarity (HubSpot, Google Workspace, SPSS) to streamline integration.

Growth potential With a revenue range of one to ten million and a lean team, pursue scalable partnerships that offer high ROI through repeatable research programs, long-term engagements, and tiered pricing for ongoing diabetes insights programs.

Strategic partnerships Target mid-to-large biotech and health outcomes organizations seeking independent, fast-turnaround patient-centric research to de-risk product development and inform pricing, reimbursement, and policy strategy.